Cefaliv® Compared to Neosaldina® in the Treatment of Migraine Attacks

NCT02706015 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Strategic reasons of the company

Conditions

Migraine Headache

Interventions

DRUG: Cefaliv® & Placebo
DRUG: Neosaldina® & Placebo

Sponsor

Ache Laboratorios Farmaceuticos S.A.